Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
Omics International publishes 98 Open Access Articles in 3 International Journals it has 2 Upcoming Conferences and 3 Previous Conferences with 147 Conference Proceedings and 31 National symposiums so far in the field.
Schizophrenia is a severe, chronic, and generally disabling brain and behaviour disorder. It is most accurately described as a psychosis a type of illness that causes severe mental disturbances that disrupt normal thoughts, speech, and behaviour. Schizophrenia is believed to be caused by a combination of genetic and environmental factors. Positive symptoms may include delusions, thought disorders, and hallucinations. People with schizophrenia may hear voices other people don't hear, or believe other people are reading their minds, controlling their thoughts, or plotting to harm them.
OMICS International through its Open access initiatives is committed to make genuine and reliable contributions to the scientific community by publishing research work and conference paper related to such disorders. It is known that ConferenceSeries hosts over 700 edge peer reviewed Open Access Journals which contains over 75000 eminent personalities, reputed scientists as editorial board members. Omics International organizes over more than 1000 Global Events annually with support from 1000 more scientific Societies. Its publishing group journals have over 5 million readers and the fame and success of the same can be attributed to the strong editorial board that ensure a quality and quick review process checker.
Scope:
The human brain has 100 billion neurons, each one of these neurons is connected to many other neurons. One neuron may have as many as 20,000 connections; there is between 100 trillion and 500 trillion neural connections in the adult human brain. There are many different parts or 'regions' of the brain. To complete a task -like recalling a memory - usually more than one region of the brain is involved, and they are connected by neural networks which are like the brain's wiring. It is believed that there are problems with the brain's wiring in schizophrenia.
List of Best International Conferences:
5th Neurology Congress
March 14-16, 2016 London, UK
5th Alzheimer’s disease and Dementia Conference
September 29-Oct 1, 2016 London, UK
2nd Brain Disorders Conference
October 27-29, 2016 Chicago, USA
2nd Neurological Disorders and Stroke Conference
April 28-30, 2016 Dubai, UAE
4th Vascular Dementia Conference
June 30-July 2, 2016 Valencia, Spain
2nd Parkinson’s disease and Movement Disorders Conference
November 28-30 Chicago USA
2nd Depression, Anxiety and Stress Management Meeting
November 3-4, 2016 Valencia, Spain
3rd Euro Psychiatry Conference
September 7-9, 2016 Amsterdam, Netherlands
Autism Conference
May 5-6, 2016 Chicago, USA
6th World Neurological conference
May 19-21, 2016 San Antonio, USA
10th International Conference on Front temporal Dementias
31 August - 2 September 2016 Munich, Germany
The International Society of Vascular Behavioural and Cognitive Disorders Conference
12 - 15 October 2016 Amsterdam, the Netherlands
14th International Athens/Springfield Symposium on Advances in Alzheimer Therapy
9-12 March 2016 Athens, Greece 24-28 July 2016 Toronto, Canada
Alzheimer's Association International Conference
22-28 July 2016, Toronto, Canada
31st International Conference of Alzheimer's disease International
21 - 24 April 2016 Budapest, Hungary
Relevant Society and Associations:
Schizophrenia Society of Alberta
Schizophrenia Society of Ontario
Schizophrenia International Research Society
Society of Biological Psychiatry
American Psychiatric Association
American Academy of Neurology
British Columbia Schizophrenia Society
Schizophrenia Society of Nova Scotia
Schizophrenia Association of Great Britain
Australian Psychological Society
Companies:
Janssen Pharmaceuticals, Inc.
Roche
Eli Lilly
SERVIER
Janssen
Johnson & Johnson
Bayer Plc
Pfizer
Eisai Ltd
Sanofi Aventis
Schizophrenia is a serious mental disorder that distorts with a person’s ability to thinks clearly, expresses emotions, make decisions and relate to others. Schizophrenia is a lifelong disease that cannot be cured but can be controlled with proper treatment. The course of mental illness is unique for each person and schizophrenia can leave its sufferer frightened and withdrawn. Based on symptoms schizophrenia are divided in to Disorganized schizophrenia, paranoid schizophrenia, catatonic schizophrenia, residual schizophrenia and undifferentiated schizophrenia. Schizophrenia is a term given to complex group of mental disorders.
Schizophrenia can be assessed by doctors through interviews with the patient as well as with family problems and friends. There is no brain imaging or single laboratory for diagnosis of schizophrenia. The positive or psychotic symptoms of schizophrenia are hallucinations and delusions, disorganized speech and behavior, lack of motivation and emotional expression, lack of energy and poor grooming habits. By observing the psychotic symptoms, schizophrenia can be diagnosed. The causes for schizophrenia are combination of environmental and genetic factors. The schizophrenia treatment includes therapy and medications to reduce the risk of symptoms. Antipsychotic medication frequently helps to relieve delusions and hallucinations. The effective treatment of schizophrenia is by therapy which includes cognitive behavioral therapy and electroconvulsive therapy.
Schizophrenia Research is research on aetiology, clinical diagnostics and different treatment of schizophrenia. Schizophrenia Research conference does not provide medical advice nor promote any product or service. Schizophrenia Research conference mainly discuss the current hypothesis about pathogenesis, causes, phenomenology and treatment of schizophrenia and related diseases. International congress or Symposium on schizophrenia is meetings where researchers representing the wide range of disciplines elaborate with discoveries in schizophrenia gather to exchange ideas, date and techniques. Schizophrenia conferences welcome all members of scientists, doctors, schizophrenia research community or association and other professional to attend this meeting. Schizophrenia Research conference mainly covers the epidemiology and possible mechanisms of schizophrenia, impact of genomics and connections approaches on schizophrenia research. Around 16 National symposiums and Workshops are going to be held across the globe which includes “International Congress on Schizophrenia Research”, European conference on Schizophrenia Research” and many more.
Market analysis:
The Schizophrenia Forum was founded in 2005 by science editor Hakon Heimer as a project of the National Alliance for Research on Schizophrenia and Depression (now called the Brain & Behaviour Research Foundation, with start-up funding from the National Institute of Mental Health. and technical assistance from the Alzheimer Research Forum website. Heimer won the 2011 Media Award from the American College of Neuropsychopharmacology for developing the site. Schizophrenia Research Forum is a web knowledge environment dedicated to news, information resources, and discussion about research on schizophrenia. It hosts a number of resources such as What We Know about Schizophrenia, Animal Models, Drugs in Trials, and the SzGene database, an unbiased field synopsis of genetic association studies performed in schizophrenia up to 2011.
This page will be updated regularly.
This page was last updated on November 22, 2024
